Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Background: Lipid-lowering therapy is very important in secondary prevention of coronary heart disease (CHD). In many clinical trials, it has been found that Sodium Tanshinone IIA Sulfonate Injection (STS) have a lipid-lowering effect while reducing major cardiovascular events in patients with CHD....
Guardado en:
Autores principales: | Hufang Zhou, Ying Zhao, Wenhua Peng, Wenbo Han, Zichen Wang, Xiaoxia Ren, Dayang Wang, Guozhong Pan, Qian Lin, Xian Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c922c50d1361492ea45811aa42d5805c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
por: Chenhui Zhong, et al.
Publicado: (2021) -
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
por: Zhang S, et al.
Publicado: (2018) -
Electronic Microscopic Evaluation of Sodium Sulfonate Effect on Hybrid Layer and Resin Tags Thickness
por: H Alaghehmand, et al.
Publicado: (2012) -
Recent insights into the biological activities and drug delivery systems of tanshinones
por: Cai Y, et al.
Publicado: (2016) -
Continuous sulfonation of hexadecylbenzene in a microreactor
por: Xu Yiming, et al.
Publicado: (2021)